Edition:
United Kingdom

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332.SS)

600332.SS on Shanghai Stock Exchange

32.14CNY
--
Change (% chg)

-- (--)
Prev Close
¥32.14
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,741,062
52-wk High
¥33.19
52-wk Low
¥23.26

Chart for

About

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is engaged in the pharmaceutical and healthcare industry. The Company's segments are Great Southern TCM, Great Commerce, Great Health and Great Medical Care. The Company's Great South TCM includes research, development, manufacturing and sales for Chinese and western... (more)

Overall

Beta: 0.73
Market Cap(Mil.): ¥43,106.98
Shares Outstanding(Mil.): 1,625.79
Dividend: 0.28
Yield (%): 2.09

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Guangzhou Baiyunshan Pharmaceutical Updates On Suspension Of Trading Of A Shares

Dec 4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:

04 Dec 2017

BRIEF-Guangzhou Baiyunshan Pharmaceutical Updates On Suspension Of A Shares

Nov 29 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:

29 Nov 2017

BRIEF-Guangzhou Baiyunshan Pharmaceutical says ‍trading in A shares to continue to be suspended​

Nov 13 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:

13 Nov 2017

BRIEF-Guangzhou Baiyunshan Pharmaceutical says ‍trading in A shares to be suspended from 31 Oct

Oct 30 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:

30 Oct 2017

BRIEF-Guangzhou Baiyunshan Pharmaceutical's 9-month net profit up 40.6 pct

Oct 22 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

22 Oct 2017

BRIEF-Guangzhou Baiyunshan Pharmaceutical says Wang Wenchu resigned as executive director

Aug 28 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd:

28 Aug 2017

Earnings vs. Estimates